These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34998990)

  • 1. Responding to signals of mental and behavioral health risk in pragmatic clinical trials: Ethical obligations in a healthcare ecosystem.
    Ali J; Morain SR; O'Rourke PP; Wilfond B; O'Brien EC; Zigler CK; Staman KL; Weinfurt KP; Sugarman J
    Contemp Clin Trials; 2022 Feb; 113():106651. PubMed ID: 34998990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
    Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
    Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and management of pragmatic clinical trial collateral findings: A current understanding and directions for future research.
    Morain SR; Mathews DJH; Geller G; Bollinger J; Weinfurt K; Jarvik JG; May E; Sugarman J
    Healthc (Amst); 2021 Dec; 9(4):100586. PubMed ID: 34600345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol.
    Taljaard M; Weijer C; Grimshaw JM; Ali A; Brehaut JC; Campbell MK; Carroll K; Edwards S; Eldridge S; Forrest CB; Giraudeau B; Goldstein CE; Graham ID; Hemming K; Hey SP; Horn AR; Jairath V; Klassen TP; London AJ; Marlin S; Marshall JC; McIntyre L; McKenzie JE; Nicholls SG; Alison Paprica P; Zwarenstein M; Fergusson DA
    Trials; 2018 Sep; 19(1):525. PubMed ID: 30261933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Meeting the Obligation of Respect for Persons in Pragmatic Clinical Trials.
    Morain SR; Kraft SA; Wilfond BS; Mcguire A; Dickert NW; Garland A; Sugarman J
    Hastings Cent Rep; 2022 May; 52(3):9-17. PubMed ID: 35763201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.
    Nicholls SG; Carroll K; Brehaut J; Weijer C; Hey SP; Goldstein CE; Zwarenstein M; Graham ID; McKenzie JE; McIntyre L; Jairath V; Campbell MK; Grimshaw JM; Fergusson DA; Taljaard M
    BMC Med Ethics; 2018 Nov; 19(1):90. PubMed ID: 30458809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
    Kalkman S; van Thiel GJ; Grobbee DE; Meinecke AK; Zuidgeest MG; van Delden JJ;
    Trials; 2016 Aug; 17(1):419. PubMed ID: 27550379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stakeholder perspectives regarding pragmatic clinical trial collateral findings.
    Morain SR; Mathews DJH; Weinfurt K; May E; Bollinger JM; Geller G; Sugarman J
    Learn Health Syst; 2021 Oct; 5(4):e10245. PubMed ID: 34667872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles and procedures for data and safety monitoring in pragmatic clinical trials.
    Simon GE; Shortreed SM; Rossom RC; Penfold RB; Sperl-Hillen JAM; O'Connor P
    Trials; 2019 Dec; 20(1):690. PubMed ID: 31815644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical Issues in the Design and Conduct of Pragmatic Cluster Randomized Trials in Hemodialysis Care: An Interview Study With Key Stakeholders.
    Nicholls SG; Carroll K; Weijer C; Goldstein CE; Brehaut J; Sood MM; Al-Jaishi A; Basile E; Grimshaw JM; Garg AX; Taljaard M
    Can J Kidney Health Dis; 2020; 7():2054358120964119. PubMed ID: 33194212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readiness assessment for pragmatic trials (RAPT): a model to assess the readiness of an intervention for testing in a pragmatic trial.
    Baier RR; Jutkowitz E; Mitchell SL; McCreedy E; Mor V
    BMC Med Res Methodol; 2019 Jul; 19(1):156. PubMed ID: 31319789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.
    Goldstein CE; Weijer C; Brehaut JC; Fergusson DA; Grimshaw JM; Horn AR; Taljaard M
    BMC Med Ethics; 2018 Feb; 19(1):14. PubMed ID: 29482537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.
    Weinfurt KP; Hernandez AF; Coronado GD; DeBar LL; Dember LM; Green BB; Heagerty PJ; Huang SS; James KT; Jarvik JG; Larson EB; Mor V; Platt R; Rosenthal GE; Septimus EJ; Simon GE; Staman KL; Sugarman J; Vazquez M; Zatzick D; Curtis LH
    BMC Med Res Methodol; 2017 Sep; 17(1):144. PubMed ID: 28923013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethics challenges in sharing data from pragmatic clinical trials.
    Morain SR; Bollinger J; Weinfurt K; Sugarman J
    Clin Trials; 2022 Dec; 19(6):681-689. PubMed ID: 36071689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' perspectives regarding pragmatic clinical trials.
    Topazian R; Bollinger J; Weinfurt KP; Dvoskin R; Mathews D; Brelsford K; DeCamp M; Sugarman J
    J Comp Eff Res; 2016 Aug; 5(5):499-506. PubMed ID: 27417953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics and Collateral Findings in Pragmatic Clinical Trials.
    Morain SR; Weinfurt K; Bollinger J; Geller G; Mathews DJ; Sugarman J
    Am J Bioeth; 2020 Jan; 20(1):6-18. PubMed ID: 31896322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.
    Marquis-Gravel G; Robertson H; Jones WS; Riley D; Ford DE; Crenshaw D; Joosten YA; Rudov L; Hernandez AF; Hess R
    Trials; 2021 Jan; 22(1):90. PubMed ID: 33494785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the ethical and regulatory issues in pragmatic clinical trials.
    Califf RM; Sugarman J
    Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stakeholder Engagement in Pragmatic Clinical Trials: Emphasizing Relationships to Improve Pain Management Delivery and Outcomes.
    Bastian LA; Cohen SP; Katsovich L; Becker WC; Brummett BR; Burgess DJ; Crunkhorn AE; Denneson LM; Frank JW; Goertz C; Ilfeld B; Kanzler KE; Krishnaswamy A; LaChappelle K; Martino S; Mattocks K; McGeary CA; Reznik TE; Rhon DI; Salsbury SA; Seal KH; Semiatin AM; Shin MH; Simon CB; Teyhen DS; Zamora K; Kerns RD;
    Pain Med; 2020 Dec; 21(Suppl 2):S13-S20. PubMed ID: 33313726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.